Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Ferenc, Uher"'
Autor:
Zsolt Matula, Viktória Király, Gabriella Bekő, Márton Gönczi, András Zóka, Róbert Steinhauser, Ferenc Uher, István Vályi-Nagy
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionSevere acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, the causative agent of coronavirus disease 2019 (COVID-19), causes post-acute infection syndrome in a surprisingly large number of cases worldwide. This conditio
Externí odkaz:
https://doaj.org/article/960576f8eb02420cbe788e7d69d45bd9
Autor:
András Ecker, Bence Lázár, Roland I. Tóth, Martin Urbán, Orsolya I. Hoffmann, Zsófia Fekete, Endre Barta, Ferenc Uher, Zsolt Matula, Eszter Várkonyi, Elen Gócza
Publikováno v:
Poultry Science, Vol 103, Iss 10, Pp 104144- (2024)
The most current in vitro genetic methods, including gene preservation, gene editing and developmental modelling, require a significant number of healthy cells. In poultry species, primordial germ cells (PGCs) are great candidates for all the above-m
Externí odkaz:
https://doaj.org/article/f52f8692225642e5960483c831a5d2ad
Autor:
Zsolt Matula, Gabriella Bekő, Viktória Király, Márton Gönczi, András Zóka, András Baráth, Ferenc Uher, István Vályi-Nagy
Publikováno v:
Vaccines, Vol 12, Iss 1, p 3 (2023)
The effectiveness of COVID-19 vaccines developed against the original virus strain deteriorated noticeably in efficacy against the Omicron variant (B.1.1.529). Moreover, the immunity developed after vaccination or due to natural infection rapidly wan
Externí odkaz:
https://doaj.org/article/c61cc75a98674963837d4ac173efbf25
Autor:
Anita Marx, Magdolna Osváth, Bence Szikora, Orsolya Pipek, István Csabai, Ákos Nagy, Csaba Bödör, Zsolt Matula, Ginette Nagy, András Bors, Ferenc Uher, Gábor Mikala, István Vályi-Nagy, Imre Kacskovics
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0285696 (2023)
The need for sensitive monitoring of minimal/measurable residual disease (MRD) in multiple myeloma emerged as novel therapies led to deeper responses. Moreover, the potential benefits of blood-based analyses, the so-called liquid biopsy is prompting
Externí odkaz:
https://doaj.org/article/72c26859dca34bd784adcddfb998a56a
Autor:
Vera Goda, Gergely Kriván, Andrea Kulcsár, Márton Gönczi, Szabolcs Tasnády, Zsolt Matula, Ginette Nagy, Gabriella Bekő, Máté Horváth, Ferenc Uher, Zoltán Szekanecz, István Vályi-Nagy
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Common variable immunodeficiency (CVID) patients have markedly decreased immune response to vaccinations. In this study we evaluated humoral and T cell-mediated responses against severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2) with addit
Externí odkaz:
https://doaj.org/article/96038290e4f341c78df964ea88bbb132
Autor:
Zsolt Matula, Márton Gönczi, Gabriella Bekő, Béla Kádár, Éva Ajzner, Ferenc Uher, István Vályi-Nagy
Publikováno v:
Vaccines, Vol 10, Iss 4, p 539 (2022)
In the present study, antibody and T cell-mediated immune responses elicited by BBIBP-CorV and BNT162b2 vaccines were compared 6 months after the two-dose immunization of healthy individuals. Additionally, antibody and T cell responses after the thir
Externí odkaz:
https://doaj.org/article/8817b0581e0f4732a443fadcb70036d9
Autor:
Ferenc Uher, Szabolcs Tasnády, Gabriella Bekő, Márton Gönczi, Éva Ajzner, Marienn Réti, Zsolt Matula, István Vályi-Nagy
Publikováno v:
GeroScience. 43:2321-2331
In the present study, humoral and T cell-mediated immune responses elicited by BBIBP-CorV (inactivated virus) and BNT162b2 (mRNA-based) vaccines against SARS-CoV-2 virus were compared. Convalescent volunteers were also investigated to evaluate adapti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3172b03f10d62fea68606a85b1f4da2d
https://doi.org/10.1007/s11357-021-00471-6
https://doi.org/10.1007/s11357-021-00471-6
Publikováno v:
International Journal of Molecular Sciences. 24:5303
Belantamab mafodotin (belamaf) is an afucosylated monoclonal antibody conjugated to the microtubule disrupter monomethyl auristatin-F (MMAF) that targets B cell maturation antigen (BCMA) on the surface of malignant plasma cells. Belamaf can eliminate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d9bb88fcf79657f8035affb78af00a2
https://doi.org/10.3390/ijms24065303
https://doi.org/10.3390/ijms24065303
Autor:
Ferenc Uher, Zsolt Matula, Márton Gönczi, László Gopcsa, Gabriella Bekő, Marienn Réti, Zoltán Szekanecz, Éva Ajzner, István Vályi-Nagy
Publikováno v:
Orvosi hetilap. 163(20)
A koronavírus-betegség (COVID–19) lefolyása rendkívül sokféle lehet. Az érintettek egy része gyakorlatilag tünetmentes marad, míg másoknál súlyos, esetenként halálos kimenetelű komplikációk alakulnak ki. Ennek a variabilitásnak a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f081a0cfa700f3478023318f1b9106e
https://pubmed.ncbi.nlm.nih.gov/35569058
https://pubmed.ncbi.nlm.nih.gov/35569058
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.